MHRA approves triheptanoin (Dojolvi) to treat adults and children with rare inherited disorders
RARE•The UK’s MHRA approved triheptanoin (Dojolvi) to treat adults and children with a group of rare inherited disorders.
1. UK approval
The UK’s MHRA approved triheptanoin (Dojolvi) to treat adults and children with a group of rare inherited disorders.
